Ignite Creation Date:
2025-12-24 @ 4:51 PM
Ignite Modification Date:
2026-03-07 @ 10:57 PM
Study NCT ID:
NCT04044950
Status:
WITHDRAWN
Last Update Posted:
2020-09-22
First Post:
2019-08-01
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase II Study of Neoadjuvant E7 TCR T Cell Immunotherapy for Borderline Resectable and Unresectable Stage I HPV-Associated Oropharyngeal Cancer
Sponsor:
National Cancer Institute (NCI)
Organization:
Organization Data
Organization:
Class:
NIH
Study ID:
190130
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
NIH
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None